ITRM
Iterum Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.79 / 10
Netural
Analyst coverage is limited but uniformly bullish (Strong Buy, 100%); yet the historical win rate is 0.0%, tempering conviction. Fund flows are positive overall (score 7.57/10), driven by block and extra-large inflows, but medium- and large-sized outflows offset momentum, creating a net neutral-to-positive tug-of-war.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-08
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for ITRM?
- ITRM holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.79/10 (Netural).
